The Gross Margin of Rigel Pharmaceuticals Inc (RIGL) is 89.60%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 89.60% |
| 2023-12-31 | 93.92% |
| 2022-12-31 | 98.59% |
| 2021-12-31 | 99.33% |
| 2020-12-31 | 99.17% |
| 2019-12-31 | 98.48% |
| 2018-12-31 | 99.33% |